Centessa Pharmaceuticals Announces $100 Million Proposed Public Offering of American Depositary Shares
GlobeNewswire
BOSTON and LONDON, April 23, 2024 (GLOBE NEWSWIRE) -- Centessa Pharmaceuticals plc (Nasdaq: CNTA), a clinical-stage..
BOSTON and LONDON, April 23, 2024 (GLOBE NEWSWIRE) -- Centessa Pharmaceuticals plc (Nasdaq: CNTA), a clinical-stage..
*Dr. David Blekhman shared insights on innovative use of hydrogen, solar power, battery storage, electrolyzers, and fuel cells for..
Tax preparer Intuit’s market valuation bigger than Goldman Sachs after becoming unexpected beneficiary of AI enthusiasm